Champions Oncology, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for CSBR, updated each market day.
CSBR AI Sentiment
AI predicts Champions Oncology, Inc. stock is likely to decrease over the next 10 market days.
Prediction date: Sept. 22, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Champions Oncology, Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment which is oncology services. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The company's pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. Its revenue is majorly derived from research services.
Sector
Exchange
Market Cap
$70,706,330
Cap Tier
Employees
214
Headquarters
BALTIMORE, MD
Listed Since
Oct. 31, 1994
CSBR Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
CSBR Volatility
Champions Oncology, Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
